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Dear Dr. Bazan, 
 
Enclosed please find the revised version of the manuscript “Re-cycling paradigms: cell cycle 
regulation in adult hippocampal neurogenesis and implications for depression”.  
 
We hope you will find it suitable for publication in Molecular Neurobiology.  
 
Sincerely, 
Luísa Pinto 
 
 
Below is an itemized list of alterations made, as well as clarifications in response to the previous 
peer-review round comments. 
 
 
Reviewer #1: 
Minor comments 
1) In this topic, the reviewer recommends that “since this review has a major emphasis on 
depression, the word should be mentioned in the title, thus distinguishing this work from 
other reviews discussing cell cycle/neurogenesis/pathology in general”.  
We agree with the reviewer’s point of view and therefore, we changed the more vague 
expression “pathology” by depression, in the title. The title of this revised manuscript is 
now: “Re-cycling paradigms: cell cycle regulation in adult hippocampal neurogenesis and 
implications for depression”. 
 
2) In this topic the reviewer argues that when discussing the literature there is a 
“generally very broad use/abuse of the term “cell cycle effects”, which reflects the lack 
of better assessments”. Moreover, he suggests that since this is a very common problem 
of the field, we should “mention at least once the limitations of these “assessments” 
(e.g. BrdU incorporation after a short pulse)”. 
According to the reviewer’s comment, we included a short mention to the limitations of 
using BrdU incorporation studies to conclude about proliferation and cell cycle alterations 
in page 12, first sentence. Moreover, and upon this comment of the reviewer #1, we also 
found appropriate to discuss the need for alternative approaches to BrdU incorporation 
studies in the last section “Conclusions and further perspectives”, page 22, paragraph 1. 
Still in this comment, the reviewer suggests that we try to describe the “real 
experiments” rather than the “author’s conclusions” when referring to previous works 
in order to critically re-evaluate the literature.  
Response to Reviewer Comments
Regarding this suggestion of the reviewer we included some descriptions of the experiments and 
BrdU incorporation paradigms used in several studies discussed throughout the manuscript (e.g. 
please see pages 10, 11, 12, 21). Moreover, we further explain and discuss when appropriate, 
the results obtained with these experimental approaches in a more integrated perspective as 
suggested by the reviewer. 
3) In this point the reviewer mentions “there are short references to a few other 
neurological diseases beyond depression, but still the authors missed a nice and 
interesting link between injury (stroke) and cell cycle length”.  
We followed the reviewer’s suggestion and added now to the revised manuscript a short 
reference to stroke in the context of cell cycle deregulation in adult neurogenesis and its 
association with the pathogenesis of several disorders (see page 15 of the revised manuscript). 
4) In this topic, the reviewer suggests a reference to a review by Salomoni & Calegari 2010, 
regarding the “link between cell cycle (cdks/cyclins) and cell fate determinants (Notch, 
Shh, Wnt) in neural stem cells”. 
In agreement with the reviewer’s suggestion we added a small reference to the interplay 
between cell cycle components and cell fate determinants in neural stem cells (first sentence of 
page 13 of the revised manuscript) and cited the review paper by Salomoni & Calegari 2010. 
Additionally, and following this comment, we found appropriate to add a sentence further 
discussing the interplay between cell fate determinants and the length of the G1 phase of the cell 
cycle (in the context of the cell cycle length hypothesis) in the last paragraph of page 9 of the 
revised manuscript. 
5) Here, the reviewer states that “Fig2 left is nearly identical to Fig1 so it would take very 
little to include Wnt and Notch in Fig1 and forget about that panel in Fig2. Similarly, 
Fig2 right will more nicely extend Fig3 when incorporated in it. As such Fig2 is 
entirely redundant”. 
As suggested by the reviewer, both alterations in the Figures were performed in the revised 
manuscript. More specifically: 
- Fig. 1 of the revised manuscript: incorporates the cell cycle and signaling components 
identified in the adult hippocampal neurogenic niche (merge of the former Fig.1 and 
Fig.2 left panel);  
- Fig. 2a of the revised manuscript: includes now the former Fig. 2 right panel (adult 
hippocampal neurogenesis process);  
- Fig. 2b of the revised manuscript: includes the former Fig. 3, panel a (cellular and 
molecular alterations observed in the hippocampal neurogenic niche of animal models 
of depression) with some alterations also suggested by the reviewer #2 (please see the 
answer to the reviewer #2, major revisions, point 2). 
- Fig. 2c of the revised manuscript: includes the former Fig. 3, panel b (cellular and 
molecular alterations observed in the hippocampal neurogenic niche after 
antidepressant treatment or other stimuli) with some alterations also suggested by the 
reviewer #2 (please see the answer to the reviewer #2, major revisions, point 2). 
 
6) This topic regards the Format and text of the manuscript. In here the reviewer states 
“wording and English can be improved”. Moreover a problem in the formatting of the 
Bibliography is addressed. Finally, it is suggested that the “figure legends are more of 
a book chapter in themself rather than a caption of a synthetic sketch”. 
Regarding the first part of the reviewer’s comment we went through the entire text and 
improved the wording and English.  
In what concerns the bibliography problem, we corrected the formatting manually, according to 
the “Instructions for authors” online file, as we were facing some problems with the endnote 
file.  
Finally, as suggested by the reviewer, the Figure legends were shortened and made clearer for 
the readers in the revised manuscript. 
 
Reviewer #2: 
Major comments: 
1) In this topic the reviewer states that “the text under “Cell cycle regulators” and “Signaling 
pathways” seems to be a list of related facts” and recommends that we ”try to develop the 
text into a logical story”, making it clearer from the start why this information is important. 
Still in this topic, we are suggested to “shorten the more general part of the manuscript and 
elaborate the latter part about depression and neurogenesis”. 
 
We think that the suggestion made by the reviewer was valuable, and thus we included a 
paragraph that we hope will serve to better explain why it is important to introduce the factors 
and pathways that have been described to regulate the adult hippocampal neurogenic niche 
(please see page 8, last paragraph of the revised manuscript). Moreover, and in agreement 
with the reviewer’s recommendation, we shorten this more descriptive part of the text and made 
it more appealing to the readers. Additionally, we further elaborated the latter part about 
depression and neurogenesis in the revised manuscript.  
 
2) In this comment the reviewer recommends that, “in addition to the figures or perhaps to 
replace some of them”, we add a “summarizing table of the different factors affecting 
the cell cycle”. Moreover, he refers that “the figures are somewhat hard to read 
because of the coloring and small size”. 
According to the reviewer’s suggestions, we added a summarizing Table of the different cell 
cycle molecules/signaling pathways implicated in the regulation of adult hippocampal 
neurogenesis in the context of depression and antidepressant drugs/stimuli.  
Additionally, in the revised manuscript, the Figures were changed in agreement to the 
suggestions made by the reviewer #1 (please see the answer to comment 5 of the reviewer #1). 
We also improved the Figures coloring (e.g. consistency of the arrows coloring in both Figures) 
and size (e.g. the vertical disposition of the panels in Figure 2 allowed us to resize each of the 
elements), to make them more perceptible to the readers, as suggested by the reviewer #2. 
3) In this topic the reviewer states that in page 18 (first version of the manuscript) the 
reference made to unpublished results from our lab is vague, further soliciting that we 
elaborate more. Moreover, he asks for a reference to published work. 
Regarding the reviewer’s comment, at the time we first submitted this manuscript, these results 
from our lab were not yet published. However, they were recently published (January 2013), 
and thus we added this reference to the revised manuscript (please see the first paragraph of 
page 18 of the revised manuscript). This work focuses on the role of new fully mature and 
incorporated neural cells in the hippocampal neurogenic niche, and its relevance for the 
spontaneous recovery from depression and for the actions of antidepressants, further 
consolidating the so-called “Neurogenic hypothesis of depression”. Therefore, and regarding the 
pertinent comment of the reviewer, we further explored this part of the manuscript (please see 
the first paragraph of page 18 of the revised manuscript). 
4) In this comment, the reviewer requests that we “discuss animal models of depression in 
more detail”, and explain “how depression is manifested in humans vs. rodents” 
(Section Major Depression). 
Concerning this reviewer’s comment, we introduced in the section entitled “Major Depression” 
more detailed information about animal models of depression (page 16 of the revised 
manuscript). We also added a brief sentence in which we describe the major behavioral 
manifestations of the human disease (page 15, first paragraph of the “Major Depression” 
section of the revised manuscript). Additionally, as suggested by the reviewer, we discussed 
some of the behavioral manifestations of depressive-like behavior in rodents and approached 
their correlation with the human disease (page 16, first paragraph of the revised manuscript). 
 
5) In this comment, the reviewer suggests that we “elaborate on the effects of voluntary 
exercise on cell cycle regulation related to adult neurogenesis”. 
According to the suggestion of the reviewer, we explored now in the revised manuscript the role 
of voluntary exercise as a pro-neurogenic and antidepressant stimulus, focusing on the changes 
it induces at the cell cycle and signaling level (please see page 21, second paragraph of the 
revised manuscript).  
6) In this topic the reviewer states that the manuscript “language is hard to understand, 
mostly because of the structure of the sentences”. Therefore, he suggests we “try 
simplifying the expressions avoiding overly long and complicated sentences”. Finally, 
he suggests that the manuscript needs to be proof-read by a native English speaker. 
We followed the reviewer’s advice, and revised all the text to make it clearer to the readers, 
namely concerning the structure of the sentences and their size. 
Moreover, the text was proof-read as suggested by the reviewer, and the appropriate changes 
were performed. 
 
 
 
Minor comments: 
1) The reviewer asked us to add the reference by Shors et al 2012 “ Use I or lose it: how 
neurogenesis keeps the brain fit for learning”. 
 
As requested by the reviewer we included in the revised manuscript the reference of Shors et al 
2012 in the corresponding sentence (please see page 4 of the revised manuscript). 
 
2) The reviewer asked us to add the reference by Gu et al 2012 “Optical controlling 
reveals time-dependent roles for adult-born dentate granule cells”. 
 
As requested by the reviewer we included in the revised manuscript the reference of Gu et al 
2012 in the corresponding sentence (please see page 6 of the revised manuscript). 
 
3) The reviewer asked us to add the reference by Nokia et al 2012 “Learning to learn: 
theta oscillations predict new learning, which enhances related learning and 
neurogenesis”. 
 
As requested by the reviewer we included in the revised manuscript the reference of Nokia et al 
2012 in the corresponding sentence (please see page 6 of the revised manuscript). 
 
4) The reviewer suggested changing the expression “physiological and pathological 
conditions” by another less vague expression. 
 
We followed the reviewer’s suggestion and replaced the expression “physiological and 
pathological conditions” by others more suitable (e.g. Physiological: basal conditions, 
homeostatic; pathological: disease throughout the revised manuscript. Please see pages 3 ,4, 7, 
14 and 23 of the revised manuscript for examples. 
 
5) The reviewer suggested that since “this review mostly concerns depression and not 
much is said about other types of pathology”, we should change the title 
 
We agree with the reviewer’s point of view and thus changed the expression “pathology” by 
“depression”, in the title, as also suggested by the reviewer #1. The title of this revised 
manuscript is now: “Re-cycling paradigms: cell cycle regulation in adult hippocampal 
neurogenesis and implications for depression”. 
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ABSTRACT 
Since adult neurogenesis became a widely accepted phenomenon, much effort has been 
put in trying to understand the mechanisms involved in its regulation. In addition, the 
pathophysiology of several neuropsychiatric disorders, such as depression, has been 
associated with imbalances in adult hippocampal neurogenesis. These imbalances may 
ultimately reflect alterations at the cell cycle level, as a common mechanism through 
which intrinsic and extrinsic stimuli interact with the neurogenic niche properties. Thus, 
the comprehension of these regulatory mechanisms has become of major importance to 
disclose novel therapeutic targets. In this review, we first present a comprehensive view 
on the cell cycle components and mechanisms that were identified in the context of the 
homeostatic adult hippocampal neurogenic niche. Then, we focus on recent work 
regarding the cell cycle changes and signaling pathways that are responsible for the 
neurogenesis imbalances observed in neuropathological conditions, with a particular 
emphasis on depression. 
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Introduction 
The view that no new neurons can be added to the adult brain was deconstructed over 
the past years. Neurogenesis in the adult mammalian brain is now a widely accepted 
neuroplastic event [1-3] that enables the brain to adapt to intrinsic and extrinsic stimuli. 
In fact, during the past few years, a large amount of data has provided evidence that the 
production, differentiation and survival of neurons in the adult brain have significant 
implications for several physiological processes, such as memory and learning [4-6]. 
Moreover, many studies have linked neurogenesis deregulation with the emergence of 
several pathological features in neuropsychiatric disorders. However, the role of 
neurogenesis in these disorders is yet to be completely established. Presently, much 
effort is devoted to the generation of behavioral and molecular data that establish a 
mechanistic link between neurogenesis and disease-state, so that ultimately directed 
therapeutic interventions can be designed. 
Adult stem cells are responsible for tissue integrity, by adding new cells to the networks 
or by promoting the capacity to repopulate mature differentiated tissues as their 
constituting cells die due to damage or degeneration. The complex process of producing 
new cells throughout an organism’s lifespan may rely on a common denominator - the 
cell cycle regulatory machinery (Fig. 1). However, the specificity of this transversal 
phenomenon in each tissue or cell type offers a wide spectrum of responses to a 
particular stem cell niche. In this review we aim to provide a comprehensive and 
integrated view of the cell cycle regulation in the adult hippocampal neurogenic niche 
both in basal conditions and in disease (namely in depression). With this, we offer a 
perspective on how the cell cycle machinery may constitute an interesting and still 
largely unrecognized link between alterations in postnatal hippocampal neurogenesis 
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and disease, highlighting its relevance for the discovery of new molecular targets for the 
treatment of neurobiological disorders. 
 
Neurogenesis in the adult mammalian brain 
 
Adult neurogenesis is the process by which neural progenitors divide mitotically to 
produce new neurons in the adult brain. This complex process involves several steps 
beyond cell division; namely, the commitment of the new cell to a neuronal phenotype, 
the migration and maturation of the cells, and the establishment of appropriate synaptic 
contacts that culminate with a full integration on the pre-existent network. Well 
described, adult neurogenesis is known to occur at least in two different regions of the 
mammalian brain: the subependymal zone (SEZ) of the lateral ventricles, and the 
subgranular zone (SGZ) of the hippocampal dentate gyrus (DG) [7]. In both regions, 
astroglial cells act as the source of adult progenitor cells [8-9]. The neuroblasts born in 
the SEZ migrate along the rostral migratory stream (RMS) becoming mostly mature 
GABAergic granule and periglomerular interneurons in the olfactory bulb (OB). The 
cells born in the adult SGZ migrate into the granular cell layer (GCL) of the DG and 
differentiate into glutamatergic granule cells [7]. Additionally, although disputable [10-
11], several reports describe the generation of new neurons in other regions of the adult 
brain, including the cortex [12-13], the amygdala [14-16], the hypothalamus [17-18], 
the striatum [19-20] and the substantia nigra [21-22]. However, in all these areas, 
neurogenesis appears to occur at very low levels or under non-physiological conditions 
[23].  
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Adult hippocampal neurogenesis  
Neurogenesis in the adult DG occurs from a progenitor population residing in a narrow 
layer of about three nuclei wide, the SGZ. The first type of progenitor cells, defined as 
multipotent, are the neural stem cells (NSCs or Type-1 cells). These cells express nestin 
and glial fibrillary acidic protein (GFAP), among other markers, and can be divided in 
two subtypes based on their orientation in the SGZ: radial astrocytes/NSCs (rA) and 
horizontal astrocytes/NSCs (hA). Radial NSCs, morphologically characterized by 
having a single radial process, are slow dividing cells, whereas horizontal NSCs have a 
short horizontal process and divide faster than rA [24-25]. Either one or both of these 
cell subtypes will then divide asymmetrically into one daughter cell and one progenitor 
cell, both of which already committed to a neuronal lineage. These latter cells, 
designated by transit amplifying neural progenitors (tANPs, or Type-2 cells), are 
mitotically active and divide to give rise to neuroblasts (also known as Type-3 cells). 
This last stage corresponds to a transition from a slow proliferating neuroblast, which is 
exiting the cell cycle, to a postmitotic immature neuron, that will migrate a short 
distance into the GCL. Neuroblasts transiently express markers of the neuronal lineage, 
such as the calcium-binding protein calretinin, doublecortin (DCX) and polysialylated-
neural cell adhesion molecule (PSA-NCAM) [10,26]. The newborn cells will then fully 
maturate into granule neurons, elongating their axons towards the  hippocampal Cornus 
Ammonis 3 (CA3) area [23] and making the appropriate axonal connections [26]. These 
adult-born neurons become integrated in the pre-existing neuronal network 4 to 8 weeks 
after their birth [3,27-29] (Fig. 2a). 
Importantly, not all cells expressing immature neuronal markers develop into fully 
mature neurons [30]. In fact, if not recruited to perform any function, the great majority 
of these newly-born cells are eliminated by apoptosis once they exit cell cycle [31-32]; a 
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mechanism that until recently was largely undescribed. However, a recent report by Lu 
et al. [33], has very elegantly shown that DCX-positive neuronal progenitors present a 
phagocytic activity in the DG as well as in the SEZ, with important implications for the 
neurogenic process [33]. 
The generation of new neurons in the hippocampal niche of the adult brain, depends on 
the harmonization of several processes and cellular activities, which include 
proliferation, cell cycle exit, activation of survival/death pathways, migration through 
the GCL and differentiation/maturation of the newborn neurons [34]. These processes 
are regulated by both intrinsic and extrinsic factors that are ultimately responsible for 
the modulation of the neurogenic phenomenon. While there are numerous focused 
studies on several of these steps, little is known about the cell cycle regulation in the 
context of adult hippocampal neurogenesis and its repercussions for disease states. 
Here, to provide an integrated view, we will consider the “expanded cell cycle” [35], 
taking into consideration some of the most well-described mitogenic signals and the 
interacting signaling pathways. 
 
Cell cycle regulation in the adult hippocampal neurogenic niche 
Providing important clues on the regulation of the adult neurogenic process, the 
expression of cell cycle proteins and their regulation have been extensively explored in 
the context of embryonic development [36-40]. On one hand, some of the mechanisms 
are common to both embryonic and adult brain; however, there are essential differences 
between them especially regarding niche properties. Whereas during development, the 
cellular environment is highly specialized to support proliferation, in the adult 
hippocampus the environmental context includes a population of fully mature and 
functionally active neurons [7,37], thus providing a different set of both intrinsic and 
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extrinsic signals. In fact, in the adult mammalian brain, the vast majority of neuronal 
cells are in a quiescent differentiated state (G0 phase of the cell cycle), which is 
probably promoted by an increase in the expression of region-specific Cdk inhibitors 
[34,41-42]. Nonetheless, the expression of cell cycle proteins in the postnatal brain and 
their definite role in this neurogenic niche are still being unveiled [36]. 
Contrary to the traditional concept that postmitotic mature neurons are stably 
maintained in a quiescent differentiated state, recent, albeit still controversial, evidence 
has demonstrated that in some disease conditions, such as Alzheimer’s disease [43-44], 
traumatic brain injury [45] and cerebral hypoxia-ischemia [46], these cells are capable 
of responding to mitogenic signals and reenter the cell cycle [35,47]. However, 
apparently these neurons neither finish dividing nor revert to their G0 quiescent state, 
ultimately undergoing apoptotic cell death and suggesting that they lack the factors 
needed for cell cycle progression [35]. 
It is important to mention, at this point, that the expression of cell cycle proteins in 
neuronal populations is not always associated with cell proliferation or cell cycle 
reentry. Indeed, a small number of studies have demonstrated that the expression of key 
cell cycle components may be associated with other neuronal processes, such as 
neuronal migration, dendrite morphogenesis, synaptic maturation and plasticity [48-49]. 
Nonetheless, a few cell cycle molecules and signaling pathways have been implicated in 
the regulation of adult hippocampal neurogenesis. Moreover, their deregulation is often 
the cause for neurogenesis imbalances observed in several disorders, such as depression. 
As such, we will first provide a brief overview on these molecules and its functions in 
the context of adult hippocampal neurogenesis. 
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Cell cycle regulators 
The cell cycle consists of a succession of events that lead to cell division. It comprises 
four distinct consecutive phases: the first gap (G1) phase, during which cells prepare for 
DNA replication in the synthetic (S) phase, followed by a second gap (G2) phase and 
mitosis (M). A highly coordinated network of molecules mediates progression through 
these four phases. There are two major classes of cell cycle regulators that cooperate in 
order to promote cell cycle progression: cyclins and cyclin-dependent kinases (Cdks). 
Cdks are serine/threonine kinases stably expressed during cell cycle progression that 
must bind to cyclins, their regulatory subunits, whose expression levels vary throughout 
the cell cycle phases, to form active catalytic heterodimers [50-51]. Each Cdk is able to 
associate with different cyclins, which will in turn determine the proteins to be 
phosphorylated by a specific Cdk-cyclin complex (Fig. 1).  
Several studies support the view that most cell cycle regulators are functionally 
redundant [52] and the need for a particular molecule is dependent on the cell type and 
on the niche [53]. This holds also true for the hippocampal neurogenic niche. As an 
example, studies on the role of Cdk4 and Cdk6 in the adult hippocampus unraveled a 
crucial role for Cdk6, but not Cdk4, in controlling the expansion of neuronal committed 
progenitors and thus the rate of neuronal production [54]. In fact, the absence of Cdk6 
was shown to induce the lengthening of the G1 phase causing premature cell cycle exit 
and differentiation [54]. These findings lead to the “cell cycle length hypothesis” [55], 
which states that proliferative divisions exhibit a short G1 phase whereas neurogenic 
divisions are characterized by longer G1 phases. In a molecular perspective, it is 
proposed that the ability of a cell fate determinant to induce any cellular response is 
related with the time it has to act during G1 [55-56]. Additionally, overexpression of the 
Cdk4-cyclin D1 complex in the adult mouse hippocampal niche was shown to increase 
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the expansion of neural progenitor cells, in a specific and cell-autonomous manner, 
while inhibiting neurogenesis [57]. Indeed, stopping the overexpression of the Cdk4-
cyclin D1 complex was accompanied by an overproduction of new neurons, 
corroborating its effect on the expansion of the neural progenitors at the expense of 
neuronal differentiation. Moreover, no effects were observed in the survival and 
maturation patterns of DCX+ immature neurons [57]. Altogether, results suggest that 
the Cdk4-Cyclin D1 complex is able to decrease the cell cycle length of cells that 
characteristically present longer cell cycles, whereas it is not able to change the short-
length cycles [57]. In line, it is proposed [55,58] that beyond the cell cycle length itself, 
it is the length relative variation that may be underlying the changes in the fate of a 
given cell [57]; yet, more studies are needed to clarify this subject.  
Cyclins, another important class of cell cycle regulators, are also implicated in the adult 
neurogenic phenomenon. Indeed, three types of cyclins D (D1, D2 and D3), which 
control Cdk4/6 activity, were already identified in mammals [59]. Although most cells 
express more than one cyclin D, several studies have demonstrated cell type-dependent 
roles for each of them [60-62]. One paradigmatic example of such specificity in the 
adult brain is the demonstration that cyclin D2, but not cyclin D1, knock-out (KO) mice, 
have a marked reduction of cell proliferation in the DG, measured by BrdU 
incorporation [59]. Other studies have corroborated this inability of cyclin D1 to 
promote neurogenesis in the hippocampus in the absence of cyclin D2 [63-64]. 
Cell cycle progression is also negatively regulated, at a post-translational level, by two 
families of cyclin-dependent kinase inhibitors: the Inhibitor of kinase 4/Alternative 
reading frame (Ink4/ARF) family and the CDK inhibitory protein/Kinase inhibitory 
protein (Cip/Kip) family. These intracellular proteins are responsible for slowing or 
arresting the progression through the cell cycle, by blocking imperative events. The 
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expression pattern and function of some of these Cdk inhibitors in the context of adult 
neurogenesis have also been characterized. P27kip1 (p27) is an important Cdk inhibitor, 
that induces cell cycle exit in proliferative cells [65]. In accordance, p27 expression 
decreases when cells are exposed to mitogenic signals, allowing their entrance in the S 
phase [66]. In the context of adult hippocampal neurogenesis, p27 protein is expressed 
in the SGZ of mice [67] and rats [64]; interestingly, many of the p27 cells co-express 
DCX in this region [67]. In vitro assays, using cultured neural progenitor cells (NPCs), 
showed rapid increases in p27 expression following differentiation by growth factor 
withdrawal, thus confirming its role in cell cycle arrest and NPCs differentiation [67]. 
Additionally, deletion of p27 promoted an increase in the proliferative pool of NPCs 
[67], in accordance with previously published results in the SEZ [68]. These data were 
corroborated by in vivo assays showing an increased number of BrdU positive cells in 
the SGZ and in the SEZ of p27 KO mice. These results, together with the increased 
levels of proliferating cell nuclear antigen (PCNA) expression in the KO animals, 
further suggest that the absence of p27 promotes NPCs proliferation in both adult 
neurogenic niches [67]. Adding to the p27 studies, Pechnick et al. carried out two 
separate studies exploring the function of p21cip1 (p21) in the mouse hippocampus [69-
70]. Using a BrdU incorporation paradigm (1 injection every two hours in a total of 
three injections, and sacrifice 24h after the first injection), the authors showed, both in 
vivo and in vitro, that the absence of p21 lead to an increased proliferation of 
hippocampal neurons. Ultimately, the work suggests that p21 is responsible for blocking 
cell cycle progression in the adult hippocampal SGZ [69-70]. Interestingly, p21 
expression is restricted to neuronal committed progenitors [70], unlike p27 that reveals 
no distinction on lineage preference [67]. Strikingly, the results are not in agreement 
with a previous report in which p21 deletion showed no impact on the proliferation of 
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neural progenitors in basal conditions [71]. However, it is worth mentioning that a 
different BrdU incorporation paradigm was used in this latter study. Indeed, the use of 
BrdU incorporation approaches has limitations as a direct measure of proliferation 
because does not always discriminates among effects that may underlie an increased S 
phase labeling; for example, G1/G2 phase shortening, increase in the growth fraction 
and lengthening of S phase [56]. The appropriate controls, the use of additional 
thymidine analogs and endogenous markers of proliferation should improve the 
analyses and may give a broader picture on the cell cycle regulatory mechanisms. 
A final word to mention E2F1, an element that is part of a broad family of transcription 
factors involved in the regulation of cell cycle progression [42], but also with important 
roles in the adult neurogenic process. Contrary to what is described for most members 
of this family, E2F1 has been reported to induce cell death, by forcing postmitotic cells 
to re-entry cell cycle [42,72]. In the context of adult neurogenesis, E2F1 was shown to 
be important for cell proliferation and differentiation. Using a single BrdU injection 
paradigm, two hours before sacrifice, Cooper-Kuhn et al. showed that E2F1-deficient 
mice have decreased cell proliferation and diminished neurogenesis, both in the 
hippocampal DG and the SVZ [72]. These authors also described a decrease of about 60 
to 70% in apoptotic cells, in the hippocampal neurogenic niche of E2F1-deficient mice 
compared to wild-type (WT), further corroborating the role of this gene in regulating 
cell death in the context of adult neurogenesis [72]. Fig. 1 depicts the cell cycle 
regulators described in the context of adult hippocampal neurogenesis. 
 
Signaling pathways 
Cell cycle entry promotion and initial progression through G1 phase is induced by 
mitogens or growth factors present in the extracellular environment [64,73-74]. The 
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interplay between cell cycle regulation and cell fate determination is also a topic of 
great relevance [56]. In particular, the G1 phase length is crucial for the switch from 
proliferation to differentiation and is modulated by cell cycle regulators and cell fate 
determinants [56]. Thus, signaling from the niche is suggested to be responsible for key 
processes in the regulation of adult neurogenesis homeostasis, including: the balance 
between quiescence versus proliferation, the mode of cell division, and the prevention 
of stem cell depletion [75-76]. In this section we will briefly describe some of the 
signaling pathways activated in the adult hippocampal neurogenic niche. 
The role of Notch signaling in NPCs in the adult hippocampus was investigated in vivo 
through inducible gain- and loss-of-function experiments. Activated Notch1 
overexpression induced proliferation of endogenous progenitors, whereas inhibition or 
ablation of Notch1 signaling promoted cell cycle exit, inducing the transition from 
neural stem or progenitor cells to transit-amplifying cells or neurons [77]. On the other 
hand, in maturing neurons, Notch1 proved to be relevant for survival and structural 
plasticity modulation [77].  
Bone morphogenetic proteins (BMPs) are other key regulatory components of the adult 
hippocampal neurogenic niche, restricting the proliferation of the stem cell pool, 
through BMP receptor-IA (BMPR-IA) activation, and thus maintaining the equilibrium 
between stem cell proliferation and quiescence [75]. Downregulation of endogenous 
BMP signaling promoted an increased proliferation of SOX2+ cells by recruiting 
quiescent radial cells into the cell cycle. Moreover, the canonical BMP signaling 
pathway is reactivated shortly after neuronal fate commitment, possibly to promote cell 
cycle exit of newly born neurons [75].  
Sonic hedgehog (Shh) is an evolutionarily conserved secreted protein that plays an 
important role in many aspects of developmental control [78], as well as in adult 
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hippocampal neurogenesis [79]. Shh signaling pathway was shown to induce a dose-
dependent proliferative response in progenitors in vitro, whereas inhibition of Shh 
signaling reduced proliferation in vivo. These studies confirmed Shh signaling pathway 
as an important regulator of adult hippocampal neural progenitors [79], suggesting also 
its involvement in cell cycle regulation.  
Like Shh, Wnt proteins are also well-known key regulators of neural stem cell behavior 
during embryonic development [80]. Wnt signaling has been reported as a regulator of 
adult hippocampal neurogenesis [81], through the activation of the proneural gene 
NeuroD1 [82]. Activation of NeuroD1 is important for the generation of granule cells in 
the hippocampus and cerebellum [83], possibly by promoting cell cycle exit.  
Altogether, these data highlight the complex orchestration of the cell cycle process in 
the context of adult hippocampal neurogenesis, as well as the interplay between cell 
cycle regulators and upstream molecular signaling pathways. Interestingly, there is a 
certain level of functional redundancy among cell cycle regulatory components, 
possibly as an evolutionary mechanism to prevent severe damage upon deficiency of 
one of these molecules. On the other hand, most of these studies point to tissue and cell 
specificity as a hallmark of these systems, proving that these regulators may operate at 
different levels of the cell cycle and implying the need for their fine tuning in the 
homeostatic control of adult hippocampal neurogenesis. 
 
Cell cycle regulation in neuropathological scenarios 
The molecular mechanisms and pathways regulating adult hippocampal neurogenesis in 
response to deleterious stimuli, and the contrasting actions of pro-neurogenic drugs, are 
still largely undisclosed. It is legitimate to consider that these alterations in adult 
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neurogenesis may be attributable to direct or indirect changes in cell cycle regulatory 
mechanisms. As such, the cell cycle machinery is possibly a convergent pathway 
through which intrinsic and extrinsic factors, such as stress and toxins, manifest their 
effects. Indeed, cell cycle deregulation in the context of adult neurogenesis has been 
associated with the pathogenesis of neurodegenerative disorders, such as Alzheimer’s 
[84] and Parkinson’s disease [85], neuropsychiatric diseases, as is the case of 
schizophrenia [86] and major depression [87], and injury, namely stroke [88-89]. These 
changes in cell cycle dynamics, as observed in several disease states [90-92], further 
reinforce the need for additional studies examining the role of core cell cycle players as 
targets for disruption. Next, we will briefly explore the case of depression as a 
paradigmatic example of how cell cycle deregulation can lead to the development of 
pathological traits. 
 
Major depression 
Major depression is a chronic and debilitating disease, and one of the most common 
psychiatric disorders in modern society. It is estimated that about 16% of the population 
will be affected by this disease once or several times during lifetime [93]. Like other 
psychiatric disorders, depression is a complex and heterogeneous clinical entity [94], 
dependent on the interaction between genetic susceptibility [95-96] and environmental 
factors [97]. Depressive patients present symptoms of depressed-mood, learned 
helplessness, anhedonia and impaired cognition, and present a high co-morbidity with 
anxiety disorders [94]. 
Strikingly, depression is characterized by several pathophysiological alterations in the 
brain such as differences in size of specific brain regions, changes in neuronal 
morphology, neurochemical and signaling alterations, and changes in genetic and 
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epigenetic regulation [98-99]. Knowledge of the etiopathogenesis of depression has 
progressed substantially in the last years [100], in part due to studies employing animal 
models. Animal models of depression use known etiological factors (etiological 
validity) to induce behavioral and neurobiological symptoms in animals similar to those 
of the human disease (face validity). Moreover, a valid animal model for the 
formulation of hypotheses and for the development of novel therapeutic strategies 
should respond to clinically effective treatments (predictive validity) [94,101]. There are 
several animal models of depression: chronic mild stress (CMS), social stress, early life 
stress, fear conditioning and olfactory bulbectomy [97]. Although none of them can 
fully recapitulate the complexity and heterogeneity of the human disease, they are 
considered robust approaches to study the depression in humans. For example, the CMS 
animal model presents alterations in the three behavioral domains known to be affected 
in depressive patients, i.e. mood, anxiety and cognition [94]. Despite this large 
contribution of data from studies in animal models of depression, and from post-mortem 
studies of human brains, the neurobiological basis of this disorder is still poorly defined. 
Importantly, the fact that approximately half of the patients presenting clinical 
depression show incomplete remission or relapse after treatment with the currently 
available antidepressants [97] further reinforces the need for finding new molecular 
targets and more efficient treatments. 
There are currently several leading hypotheses that attempt to elucidate the neural and 
molecular mechanisms of depression. The monoamine hypothesis of depression [102] 
has been the most prevalent. The main support of this hypothesis is the fact that most 
classic antidepressants induce an increase of the serotonin and noradrenaline levels 
[103]. More recently, additional studies have shown that other mechanisms are 
implicated in the neurobiology of this disorder; this is mostly based on the observation 
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that other factors are altered in depressed individuals [87,104-105] and on the efficacy 
of new antidepressants, in which the mechanisms of action do not rely on the 
monoamine transmission systems [106-109]. Thus, several other hypotheses on the 
etiology of depression have been put forward, including: the neurotrophin hypothesis, 
the cytokine hypothesis, the hypothalamic pituitary adrenal (HPA) axis modulation 
hypothesis and the neurogenic hypothesis. Although none of these are mutually 
exclusive, herein we will focus mostly on the role of adult hippocampal neurogenesis 
and on the molecular processes that can regulate it at the cell cycle level.  
 
The neurogenic hypothesis of depression and cell cycle (de)regulation  
Studies showing reduced hippocampal neurogenesis in several animal models of 
depression [110-112] constitute the basis for the neurogenic hypothesis of depression. 
Importantly, all major classes of antidepressants [87,113], and most of the 
environmental factors that confer antidepressant-like behavioral effects, such as 
environmental enrichment [114-115], physical activity [115] and learning [7], are also 
known to promote hippocampal neurogenesis. These facts have lead to the proposal that 
neurogenesis may have a role in the etiopathogenesis of depression; however, the 
currently available data strongly reinforces the need for restructuring this possibly 
oversimplified view. Indeed, the functional implications of decreased neurogenesis for 
the precipitation and maintenance of the depressive state are yet to be completely 
established, as the experimental approaches and time frames of analysis diverge. Some 
studies have implicated neurogenesis in the emergence of behavioral deficits observed 
in animal models of depression and in the actions of antidepressants [116-118]. While, 
other studies showed that at least the short-term mood-improving actions of 
antidepressants depend on neuronal remodeling in the hippocampus and prefrontal 
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cortex (PFC), rather than on neurogenesis [110]. Moreover, recently published data 
from our lab showed that the appropriate incorporation of new cells in the adult rat 
hippocampus is a key factor for the long-term spontaneous recovery from depressive-
like behavior as well as for the action of antidepressants [119]. Using a longer 
experimental time frame, to allow the full differentiation and integration of newborn 
cells in the pre-existing neuro-glial circuitry, it was possible to fate-map the new cells 
generated during antidepressants treatment and understand their impact in distinct 
behavioral dimensions [119]. These findings further reinforce the need for an integrated 
time-dependent overview of the neurogenic phenomenon with great emphasis on the 
functional role of newly generated cells in the adult hippocampus. Importantly, most of 
the stimuli affecting adult neurogenesis, are also responsible for inducing changes at the 
cell cycle level in the progenitor cells of the hippocampal niche. Some of the most 
relevant reports on cell cycle regulation in the context of adult hippocampal 
neurogenesis and stress-related disorders have disclosed a major role for Cdk inhibitors 
[64,69-70]. Heine et al. evaluated the role of p27 in the regulation of the cell cycle in 
the DG of rats following exposure to stress [64]. After three weeks of chronic exposure 
to unpredictable stress, rats presented significantly decreased numbers of proliferating 
cells, measured by ki67 immunostaining, and increased numbers of p27 positive cells in 
the SGZ. Notably, this effect was not observed upon acute stress exposure. Moreover, 
the proliferation levels returned to normal after a 3–week recovery period from chronic 
stress, suggesting a transient p27-dependent G1 arrest in the SGZ cells of chronically 
stressed animals [64]. Somehow unexpectedly, neither Cyclin-E nor Cyclin-D1 protein 
levels were significantly altered in these animals when compared to controls [64]. 
Other animal studies have focused their attention on the role of Cdk inhibitors regarding 
the pro-neurogenic action of antidepressants [69-70]. Pechnick et al. showed that naïve 
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mice chronically treated with imipramine, a tricyclic antidepressant, not only show 
increased neurogenesis in the DG but also decreased the expression of p21 Cdk 
inhibitor in the SGZ, when comparing to saline-treated controls [69]. In a more recent 
study, the same group analyzed the effects of chronic administration of other classes of 
antidepressants on SGZ p21 expression and neurogenesis; all antidepressants tested 
(fluoxetine, imipramine and desipramine) were able to specifically inhibit p21 
expression in the mice DG and this effect was linked to increased neurogenesis [70]. 
Unexpectedly, no change was noted in p27 expression following antidepressants 
administration [70], possibly suggesting specific roles for each of these Cdk inhibitors 
following different stimuli. It is worth mentioning that Pechnick et al. did not include an 
animal model of depression in their studies, possibly accounting for these results. 
Together, these findings support the involvement of cell cycle molecules in the 
mechanistic association between stress and the action of antidepressants, in the context 
of neurogenesis regulation. 
A recent study has implicated the cyclin dependent kinase 5 (Cdk5)/p35 complex in the 
development of depressive-like behavior and in the action of antidepressants [120]. 
Cdk5 still has no recognizable function in the progression of the cell cycle [37,47], 
although structurally similar to other Cdks. In fact, Cdk5 expression and activity occur 
almost exclusively in postmitotic neurons, both in the developing and in the adult brain 
[37]. This kinase works as a cell cycle inhibitor in postmitotic neurons, repressing 
aberrant cell cycle reentry, a phenomenon linked to the development of several 
neurodegenerative disorders [37,121]. Cdk5 regulation requires activators that are 
specifically expressed in postmitotic neurons. One of these activators is p35, a 
regulatory subunit that translocates from the cytosol to the membrane to induce Cdk5 
activity [120-121]. In a recent study, it was reported an increased Cdk5 kinase activity 
20 
 
together with the translocation of p35 to the cell membrane, in the DG of rats exposed 
to CMS. They also observed that inhibition of Cdk5 specifically in the DG, but not in 
the CA1 or CA3 of the hippocampus, prevented the CMS-induced behavioral 
impairments, further suggesting the involvement of the Cdk5/p35 complex in the 
etiology of depressive-like behavior. Remarkably, p35 overexpression blocked the 
antidepressant behavioral effects of venlafaxine, a selective serotonin reuptake inhibitor 
(SSRI) antidepressant [120]. These data suggest an association between Cdk5 activity 
and the development of stress-related disorders [120], similarly to what has been 
previously described for some neurodegenerative disorders [121]. Moreover, the studies 
may also suggest that the effect of Cdk5 activation is attributable to the impairments 
typically observed in hippocampal neurogenesis induced by CMS exposure [120]. 
Complementary studies with analyses of cell proliferation and neurogenesis would help 
to better define Cdk5 function in the adult hippocampus. Figures 2b and 2c are 
schematic representations of the adult hippocampal neurogenesis changes observed in 
animal models of depression and after antidepressant treatment, and the corresponding 
cell cycle alterations. 
Changes in the signaling pathways known to be involved in the modulation of adult 
hippocampal neurogenesis have also been indirectly associated with the development of 
depressive-like behavior in animal models. Indeed, Wnt knockdown-mediated 
neurogenesis ablation was shown to impair several hippocampal-dependent cognitive 
functions, such as long-term retention of spatial memory and object recognition 
memory [122]. Importantly, these cognitive behavioral deficits were linked with 
depression onset and maintenance [94,123]. Wnt signaling was further implicated in the 
actions of fluoxetine, a SSRI antidepressant; chronic treatment with this antidepressant 
was able to stimulate the expression of Wnt3a protein in the hippocampal DG. 
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However, Wnt activity appears to be preferentially implicated in fluoxetine’s reported 
induction of neural plasticity and not in its pro-neurogenic actions [124]. 
Notch and BMP signaling have also been shown to be mediators of the pro-neurogenic 
actions of physical exercise. Physical exercise is a stimulus with recognized 
antidepressant effects [125-126]. Moreover, it has been consistently reported to robustly 
induce adult hippocampal neurogenesis, by promoting the proliferation of progenitors 
and the survival and maturation of newborn neurons [127-130]. More recently, some 
studies investigated the molecular signaling correlates of these cellular events [131-
133]. Using thymidine analogs incorporation paradigms, Brandt et al showed that 
voluntary exercise (i.e. mice that had access to a running wheel) preferentially promotes 
the proliferation of DCX+ type-3 precursor cells and Notch1-dependent cell cycle exit. 
Since Notch1 is known to induce proliferation and inhibit differentiation in earlier 
neural progenitor cells (type-1 and 2a cells) [77], it is interesting to notice these 
contrasting pro-neurogenic functions in more committed progenitors [132]. Altogether 
the findings support the use of experimental designs that specifically address the role of 
molecular determinants in each hippocampal cell type. Table 1 summarizes the most 
relevant studies regarding the cell cycle and signaling alterations implicated in adult 
hippocampal neurogenesis imbalances in the context of depressive-like behavior. 
 
 
 
Conclusions and perspectives 
Sixty years after the first report of ongoing neurogenesis in the adult brain, we are now 
at the point of evaluating the physiological relevance of the incorporation of new 
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neurons in pre-existing neuronal networks. The integrated studies on adult neurogenesis 
in its various stages – progenitor cells proliferation, cell cycle exit, migration and 
differentiation – have brought new players into the complex network of factors and 
molecular mediators that directly or indirectly participate in the process. Nonetheless, 
we were not yet able to establish the precise molecular cascades that regulate the 
homeostasis in adult neurogenic niches. Therefore, the future of this field of research 
needs to build up an integrated view of the molecular processes, by specifically 
targeting candidate molecules using conditional approaches to overcome the limitations 
of full-KO models. This approach will allow the exclusion of possible compensatory 
mechanisms promoted during embryonic development, a strategy that seems to be of 
particular importance in the case of cell cycle regulators. Additionally, most of the 
literature on the regulation of adult neurogenesis relies on the use of thymidine analogs 
incorporation, such as BrdU. The use of these strategies to study cell cycle regulation in 
the context of adult hippocampal neurogenesis requires careful interpretation of the 
data. In this way, the appropriate controls and additional strategies should be considered 
to ensure that the results definitely reflect the generation of new neural cells. Moreover, 
caution is needed when comparing different studies, as distinct experimental paradigms 
may draw contrasting conclusions. 
More than a physiological phenomenon, adult hippocampal neurogenesis is a process by 
which the etiology of many neurodegenerative and neuropsychiatric disorders may be 
unraveled. More importantly, the neurogenic process is a substrate from which new 
molecular targets for treating these disorders may arise. The diverse ways of 
approaching the topic provide unique perspectives on how neurogenesis may be 
implicated in homeostatic responses and in the development of pathological states. The 
data reviewed here strongly supports that both direct and indirect cell cycle regulatory 
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events may constitute relevant pieces to elucidate the complex mechanisms underlying 
the response to anti- and pro-neurogenic stimuli, in both basal conditions and in disease. 
These reports further emphasize the pertinence of modulating cell cycle regulators as 
targets for the development of new therapeutic approaches for disorders associated with 
neuroplastic imbalances. 
Particularly in the case of major depression, new theories beyond monoamines have 
created a broader picture on how etiological factors are translated into disease and the 
action of antidepressants into the alleviation of the most common symptoms. In this 
context, much of the mechanisms are now being explored, including those interfering 
with adult hippocampal neurogenesis. However, the study of depression still represents 
a challenge for research since it involves the interplay between an individual’s genetic 
predisposition and molecular responses to environment. Certainly, the discovery of new 
molecular mediators will give us important clues on susceptibility or predisposition 
targets, promoting the establishment of novel disease models, in a feedback loop that 
would nourish the field with new perspectives. 
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FIGURE CAPTIONS 
 
Fig. 1 Cell cycle regulation in the adult hippocampal neurogenic niche. Some niche-
specific cell cycle regulators in the adult hippocampus have been identified. Cdk6-
cyclin D2 and Cdk4-cyclin D1 complexes promote the expansion of the neural 
progenitor pool. P21 and p27 Cdk inhibitors have a role in proliferation arrest, both at 
the G1 and G2 phase. E2F1 has an important role in the neurogenic process by inducing 
the expression of genes involved in cell proliferation and differentiation. Cdk5 activity 
is associated with cell cycle reentry inhibition in postmitotic neurons. Signaling 
pathways, such as Notch, BMP, Shh and Wnt, are also involved in proliferation 
regulation, and in the balance between proliferation induction and stem cell quiescence 
maintenance. Nevertheless, several key molecules remain to be identified in this process 
in the context of adult hippocampal neurogenic niche (represented in the figure by a 
question mark). Rb – retinoblastoma protein. 
 
Fig. 2 (a) Neurogenesis in the hippocampus comprises several steps, including 
proliferation of neural stem cells and transit amplifying neural progenitors in the 
subgranular zone (SGZ), cell cycle exit, neuroblasts migration throughout the granule 
cell layer (GCL), and maturation of the newborn neurons. (b,c) Cell cycle regulators 
implicated in neurogenesis imbalances observed in animal models of depression and in 
the pro-neurogenic effects of antidepressant drugs and other stimuli. (b) Neurogenesis 
imbalances have been observed in animal models of depression. These imbalances are 
attributed to an increased expression of p27 Cdk inhibitor (green arrow) in the DGs of 
animal models of depression. P27 inhibits neural progenitor cells proliferation in this 
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neurogenic niche. Cdk5 is involved in the development of depressive-like signs in an 
animal model of depression. The increased activity of Cdk5 (green arrow), together with 
the translocation of p35 activator to the membrane, was observed in chronic mild stress 
(CMS) exposed animals. (c) The pro-neurogenic actions of antidepressant drugs and 
stimuli, such as physical exercise, have also been correlated with alterations in the 
“expanded cell cycle”. Antidepressants are able to specifically inhibit p21 expression 
(red arrow) in the DG, while increasing neurogenesis. Additionally, signaling pathways 
with recognized effects over the cell cycle regulation, such as Wnt, Notch and BMP, 
were implicated in the modulation of adult hippocampal neurogenesis in the context of 
depression and antidepressant stimuli. 
 
TABLE CAPTION 
Table 1 Summary of the cell cycle and signaling alterations implicated in neurogenesis 
imbalances observed in animal models of depression and mediating the pro-neurogenic 
effects of antidepressant drugs and stimuli. SGZ – Subgranular zone; DG- dentate 
gyrus; CUS – chronic unpredictable stress; CMS – chronic mild stress; AD – 
antidepressants; DCX – doublecortin [64,69-70,120,124,132] 
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TABLE 1 
Experimental model 
Proliferation/neurogenesis in the 
hippocampal DG 
Molecular changes Reference 
Cell cycle regulators 
CUS exposed mice  
 p27kip1 + cells in the 
SGZ of the DG 
[64] 
Naïve mice chronically treated 
with fluoxetine, imipramine and 
desipramine 
 
 p21cip expression in the 
SGZ of the DG 
[69-70] 
CMS exposed rats treated with 
venlafaxine, mirtazapine, and 
aripiprazole 
(Not assessed) 
 Cdk5 activity and 
translocation of p35 
activator to the membrane 
[120] 
Signaling pathways 
Naïve animals chronically 
treated with fluoxetine 
  Wnt3a expression [124] 
Voluntary exercise in mice 
(antidepressant stimulus) 
 
 Notch1 activity in DCX+ 
cells (cell cycle exit 
promotion) 
[132] 
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